Another Lurasidone Setback As Takeda Exits Alliance
This article was originally published in The Pink Sheet Daily
Executive Summary
Takeda has ended an alliance with fellow Japanese firm Sumitomo Dainippon for Latuda (lurasidone), dealing the second major blow to the atypical antipsychotic in recent weeks.